LynkDose LynkDose
Growth Hormone GHRH analog

CJC-1295

Also known as: CJC-1295 no-DAC · Mod GRF (1-29)

A growth-hormone-releasing hormone (GHRH) analog discussed for prompting the pituitary to release the body’s own growth hormone, most often paired with a GH secretagogue like Ipamorelin.

Class

GHRH analog

Default unit

mg

Common route

Subcutaneous

Typical half-life

~30 min (no-DAC form)

Frequency

Daily, often split doses

Commonly associated areas

Illustrative map of the body systems CJC-1295 is most often discussed in relation to. Relative emphasis only — not a measure of efficacy or a medical claim.

Growth-hormone release 90
Recovery 64
Body composition 60
Sleep quality 55
Skin & collagen 40

Proposed mechanisms / pathways

GHRH receptor Pituitary stimulation Increased GH pulse amplitude

What is CJC-1295?

CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog — a modified fragment of the body’s own GHRH that is discussed in the context of signaling the pituitary gland to release more of its own growth hormone, rather than introducing growth hormone directly. The common "no-DAC" version (also called Mod GRF 1-29) is short-acting, while a separate DAC variant is engineered to stay active far longer.

How it is thought to work

CJC-1295 is thought to bind the GHRH receptor on the pituitary, increasing the amplitude of the body’s natural GH pulses. Because a GHRH analog and a GH secretagogue act through different but complementary pathways, CJC-1295 is frequently paired with a peptide like Ipamorelin — the idea being that one raises the "volume" of the pulse while the other helps trigger it.

Educational only — not medical advice

CJC-1295 is a research peptide and is not an approved medication for general human use. Nothing here is a recommendation, dose, or medical claim. Consult a qualified healthcare provider and follow the laws in your area.

Tracking CJC-1295 in LynkDose

Because CJC-1295 is usually run as part of a pair, the most useful habit is logging each compound separately with its dose and time of day. The effects people look for — recovery, sleep, and body composition — build slowly, so let objective metrics from Apple Health accumulate. In LynkDose the value comes from the multi-week trend, which is exactly what a tracker is built to surface.

Commonly discussed for

  • Supporting the body’s natural growth-hormone release
  • Recovery and body-composition goals over longer timeframes
  • Complementing a GH secretagogue in a paired protocol

Often stacked: Very commonly paired with a GH secretagogue such as Ipamorelin, combining a GHRH analog with a GH-releasing peptide.

How to track CJC-1295 in LynkDose

CJC-1295 is often dosed alongside another peptide, so log each compound, dose, and time separately. Then watch recovery, sleep, and body-composition trends accumulate over weeks rather than days.

Deeper read: How to Track a Peptide Cycle: A Complete Guide

Not medical advice

This page is educational and does not recommend, prescribe, or dose any compound. Many peptides are research chemicals not approved for general human use. Always consult a qualified healthcare provider and follow the laws in your area.

Related peptides